Mark S. Ordan is the Chief Executive Officer of Pediatrix Medical Group, Inc., a leading provider of newborn, maternal-fetal, and pediatric subspecialty care in the United States. With over three decades of experience in healthcare finance and operations, Ordan joined Pediatrix in 2012 as Executive Vice President and Chief Financial Officer, where he played a pivotal role in strengthening the company's financial foundation amid a dynamic industry landscape. Prior to Pediatrix, he served as Senior Vice President and Chief Financial Officer at Health Management Associates (HMA) from 2008 to 2012, overseeing financial strategy during a period of significant growth and merger activity. His earlier career included key finance leadership positions at Magellan Health Services and investment banking roles at Alex. Brown & Sons, honing his expertise in strategic financial planning and capital markets. In 2015, Ordan advanced to President and Chief Operating Officer at Pediatrix, expanding his oversight to include operational excellence, clinical integration, and business development. He assumed the CEO role in May 2018, guiding the company through transformative initiatives such as enhancing physician-led care models, expanding subspecialty services, and navigating regulatory and reimbursement challenges. Under his leadership, Pediatrix has achieved sustained revenue growth, improved patient outcomes, and strategic partnerships that have solidified its position as a national leader in perinatology and neonatology. Ordan's achievements include driving Pediatrix's focus on innovation, such as telehealth advancements and data-driven clinical programs, while maintaining a commitment to high-quality, cost-effective care. A certified public accountant and MBA graduate from the University of Florida, he is recognized for his disciplined approach to governance and his dedication to advancing pediatric healthcare accessibility.